As of April 15, 2025, Apellis Pharmaceuticals (APLS) has a market cap of $2.38 billion USD. According to our data, Apellis Pharmaceuticals is ranked No.3717 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 15, 2025 | $2.38 B |
-40.01%
|
Dec 31, 2024 | $3.97 B |
-46.69%
|
Dec 29, 2023 | $7.45 B |
15.76%
|
Dec 30, 2022 | $6.43 B |
9.37%
|
Dec 31, 2021 | $5.88 B |
-17.34%
|
Dec 31, 2020 | $7.12 B |
86.81%
|
Dec 31, 2019 | $3.81 B |
132.15%
|
Dec 31, 2018 | $1.64 B |
-39.22%
|
Dec 29, 2017 | $2.70 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() BioCryst Pharmaceuticals
BCRX
|
$1.55 B |
-0.000 M
|
![]() USA
|
![]() Sarepta Therapeutics
SRPT
|
$5.28 B |
-0.000 M
|
![]() USA
|
![]() Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
![]() USA
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Biogen
BIIB
|
$17.12 B |
0.000 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
Market Cap | = | APLS Stock Price | * | APLS Shares Outstanding |
= | $18.97 | * | 0.13 B | |
= | $2.38 B |